Following up my straw from a few weeks ago, is this the breakout price action we have been looking for?

Above the significant zone of resistance on good volume, and a close near the high of the day. If this holds and/or follows through, you have to be bullish.

Visiting the scene of the crime after my last technical update a couple of months ago, and after a brief halt in the momentum and pullback due to (yet another - this business has a habit of doing these!) capital raise, the shares seem to be building up the energy to break out of that 20-21c range again. On close watch.

A change of management (with the new CEO buying a reasonable amount of shares on-market), positive developments on the push towards making bioimpedance spectroscopy the standard of care for lymphodema from the NCCN, and an overarching risk-on sentiment in pockets of the biotech market have together conspired to re-rate the shares sharply higher here (@Metis must be stoked with his huge 33% stake!).

Technically, the stock has behaved well, consolidating its initial thrust where it more than doubled in a day, retesting that breakout and then beginning its next leg higher over the past few trading sessions. If it breaks through resistance at around 20-21c on good volumes, it could push well higher. Worth watching on account of fundamental and technical improvements conspiring to reward risk tolerant punters.